Published in Front Immunol on June 26, 2017
Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature (2007) 14.28
Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med (2006) 13.74
T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol (2007) 12.20
Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology (2011) 12.09
Increased expression of interleukin 17 in inflammatory bowel disease. Gut (2003) 9.16
Macrophage receptors and immune recognition. Annu Rev Immunol (2005) 5.83
Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells. Nature (2007) 4.88
Diphtheria toxin receptor-mediated conditional and targeted cell ablation in transgenic mice. Nat Biotechnol (2001) 4.82
Resident and pro-inflammatory macrophages in the colon represent alternative context-dependent fates of the same Ly6Chi monocyte precursors. Mucosal Immunol (2012) 2.73
The mononuclear phagocyte system. Curr Opin Immunol (2005) 2.65
Immune complex relay by subcapsular sinus macrophages and noncognate B cells drives antibody affinity maturation. Nat Immunol (2009) 2.49
Regulation of gut inflammation and th17 cell response by interleukin-21. Gastroenterology (2008) 2.38
CD169-positive macrophages dominate antitumor immunity by crosspresenting dead cell-associated antigens. Immunity (2010) 2.37
Critical role of macrophages in the marginal zone in the suppression of immune responses to apoptotic cell-associated antigens. J Clin Invest (2007) 2.34
Th1/Th17 immune response is induced by mesenteric lymph node dendritic cells in Crohn's disease. Gastroenterology (2009) 2.15
CX3CR1 regulates intestinal macrophage homeostasis, bacterial translocation, and colitogenic Th17 responses in mice. J Clin Invest (2011) 2.08
Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer. Nat Rev Gastroenterol Hepatol (2009) 1.80
CD169+ macrophages at the crossroads of antigen presentation. Trends Immunol (2011) 1.44
Marginal zone macrophages suppress innate and adaptive immunity to apoptotic cells in the spleen. Blood (2011) 1.42
Th17 cells induce colitis and promote Th1 cell responses through IL-17 induction of innate IL-12 and IL-23 production. J Immunol (2011) 1.39
Intestinal lamina propria retaining CD4+CD25+ regulatory T cells is a suppressive site of intestinal inflammation. J Immunol (2007) 1.21
CD169 mediates the capture of exosomes in spleen and lymph node. Blood (2013) 1.20
Synergy of IL-23 and Th17 cytokines: new light on inflammatory bowel disease. Neurochem Res (2009) 1.10
Sialoadhesin in recognition of self and non-self. Semin Immunopathol (2012) 1.05
Gut-associated lymphoid tissue, T cell trafficking, and chronic intestinal inflammation. Ann N Y Acad Sci (2010) 1.04
Role of Th17 Cells in the Pathogenesis of Human IBD. ISRN Inflamm (2014) 1.04
Marginal zone CD169+ macrophages coordinate apoptotic cell-driven cellular recruitment and tolerance. Proc Natl Acad Sci U S A (2014) 1.02
Sialoadhesin - a macrophage-restricted marker of immunoregulation and inflammation. Immunology (2013) 1.02
CD169-positive macrophages in regional lymph nodes are associated with a favorable prognosis in patients with colorectal carcinoma. Cancer Sci (2013) 0.94
Inflammatory bowel diseases: controversies in the use of diagnostic procedures. Dig Dis (2009) 0.93
The role of lymph node sinus macrophages in host defense. Ann N Y Acad Sci (2014) 0.91
The lymph nodes draining the small intestine and colon are anatomically separate and immunologically distinct. Mucosal Immunol (2015) 0.90
Microbiota regulation of inflammatory bowel disease and colorectal cancer. Semin Cancer Biol (2013) 0.90
Intestinal CD169(+) macrophages initiate mucosal inflammation by secreting CCL8 that recruits inflammatory monocytes. Nat Commun (2015) 0.88
The macrophage paradox. Immunity (2014) 0.86
Role of the gut-associated and secondary lymphoid tissue in the induction of chronic colitis. Inflamm Bowel Dis (2010) 0.84
Inflammatory bowel disease: the classic gastrointestinal autoimmune disease. Curr Probl Pediatr Adolesc Health Care (2014) 0.84
The identification and developmental requirements of colonic CD169⁺ macrophages. Immunology (2014) 0.83
miR-10a inhibits dendritic cell activation and Th1/Th17 cell immune responses in IBD. Gut (2014) 0.81
Influence of environmental factors in the development of inflammatory bowel diseases. World J Gastrointest Pharmacol Ther (2016) 0.80
Itch inhibits IL-17-mediated colon inflammation and tumorigenesis by ROR-γt ubiquitination. Nat Immunol (2016) 0.79
Hemidesmosome integrity protects the colon against colitis and colorectal cancer. Gut (2016) 0.78
The Faroese IBD Study: Incidence of Inflammatory Bowel Diseases Across 54 Years of Population-based Data. J Crohns Colitis (2016) 0.78
Critical role of CCL22/CCR4 axis in the maintenance of immune homeostasis during apoptotic cell clearance by splenic CD8α(+) CD103(+) dendritic cells. Immunology (2016) 0.78
CD169 identifies an activated CD8(+) T cell subset in regional lymph nodes that predicts favorable prognosis in colorectal cancer patients. Oncoimmunology (2016) 0.75
Steatohepatitis: PARP inhibition protective against alcoholic steatohepatitis and NASH. Nat Rev Gastroenterol Hepatol (2016) 0.75
Status of colitis-associated cancer in ulcerative colitis. World J Gastrointest Oncol (2016) 0.75